Diabète de type 2 cétonurique et virus de l’herpès humain de type 8

Jean-François Gautier

doi:doi:10.1051/medsci/20082467665

Accès gratuit

Numéro		Med Sci (Paris) Volume 24, Numéro 6-7, Juin-Juillet 2008


Page(s)		665 - 666
Section		Dernière Heure
DOI		http://dx.doi.org/10.1051/medsci/20082467665
Publié en ligne		15 June 2008

Mauvais-Jarvis F, Sobngwi E, Porcher R, et al.Ketosis-prone type 2 diabetes in patients of sub- Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004; 53 : 645–53.
Sobngwi E, Mauvais-Jarvis F, Vexiau P, et al.Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 2001; 27 : 628–34.
Sobngwi E, Mauvais-Jarvis F, Vexiau P, et al.Diabetes in africans. Part 2 : ketosis prone atypical diabetes mellitus. Diabetes Metab 2002; 28 : 5–12.
Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 2006; 144 : 350–7.
Sobngwi E, Gautier JF. Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia 2002; 45 : 283–5.
Umpaichitra V, Bastian W, Taha D, et al.C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus. J Clin Endocrinol Metab 2001; 86 : 1605–9.
Umpierrez GE, Casals MM, Gebhart SP, et al.Diabetic ketoacidosis in obese African-Americans. Diabetes 1995; 44 : 790–5.
Schulz TF. Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. J Antimicrob Chemother 2000; 45 (suppl 3) : 15–27.
Crispo A, Tamburini M, De Marco MR, et al.HHV- 8 prevalence, immunosuppression and Kaposi’s sarcoma in South Italy. Int J Mol Med 2001; 7 : 535–8.
Weissmann A, Linn S, Weltfriend S, Friedman- Birnbaum R. Epidemiological study of classic Kaposi’s sarcoma: a retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol 2000; 14 : 91–5.
Sobngwi E, Choukem SP, Agbalika F, et al.Ketosis prone type 2 diabetes and human herpes virus 8 infection in sub-Saharan Africans. JAMA 2008; 299 : 2770–6.

[1] Mauvais-Jarvis F, Sobngwi E, Porcher R, et al.Ketosis-prone type 2 diabetes in patients of sub- Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004; 53 : 645–53.

[2] Sobngwi E, Mauvais-Jarvis F, Vexiau P, et al.Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 2001; 27 : 628–34.

[3] Sobngwi E, Mauvais-Jarvis F, Vexiau P, et al.Diabetes in africans. Part 2 : ketosis prone atypical diabetes mellitus. Diabetes Metab 2002; 28 : 5–12.

[4] Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 2006; 144 : 350–7.

[5] Sobngwi E, Gautier JF. Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia 2002; 45 : 283–5.

[6] Umpaichitra V, Bastian W, Taha D, et al.C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus. J Clin Endocrinol Metab 2001; 86 : 1605–9.

[7] Umpierrez GE, Casals MM, Gebhart SP, et al.Diabetic ketoacidosis in obese African-Americans. Diabetes 1995; 44 : 790–5.

[8] Schulz TF. Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. J Antimicrob Chemother 2000; 45 (suppl 3) : 15–27.

[9] Crispo A, Tamburini M, De Marco MR, et al.HHV- 8 prevalence, immunosuppression and Kaposi’s sarcoma in South Italy. Int J Mol Med 2001; 7 : 535–8.

[10] Weissmann A, Linn S, Weltfriend S, Friedman- Birnbaum R. Epidemiological study of classic Kaposi’s sarcoma: a retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol 2000; 14 : 91–5.

[11] Sobngwi E, Choukem SP, Agbalika F, et al.Ketosis prone type 2 diabetes and human herpes virus 8 infection in sub-Saharan Africans. JAMA 2008; 299 : 2770–6.

Prix Nobel 2012